|
Volumn 28, Issue 2, 1996, Pages 538-539
|
Xenoislet rejection following pig-to-rat, pig-to-primate, and pig-to-man transplantation
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
15 DEOXYSPERGUALIN;
ANTIBODY;
C PEPTIDE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
GLUCAGON;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
LEFLUNOMIDE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
RAPAMYCIN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CELL INFILTRATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIABETES MELLITUS;
GRAFT REJECTION;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
MONKEY;
MONONUCLEAR CELL;
NONHUMAN;
PANCREAS ISLET TRANSPLANTATION;
PRIORITY JOURNAL;
RAT;
SWINE;
XENOTRANSPLANTATION;
ANIMALS;
DIABETES MELLITUS, TYPE 1;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ISLETS OF LANGERHANS TRANSPLANTATION;
KIDNEY;
MACACA FASCICULARIS;
PRIMATES;
RATS;
RATS, INBRED LEW;
RATS, WISTAR;
SWINE;
T-LYMPHOCYTES;
TRANSPLANTATION, HETEROLOGOUS;
|
EID: 0029929605
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (10)
|
References (0)
|